Abstract
The new isoprenylated tetrahydroxyxanthone, 2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9H-xanthen-9-one (1), was isolated from the root bark of Cudrania tricuspidata together with macluraxanthone B (2) and cudraxanthone L (3), which were fully characterized by NMR spectroscopic and X-ray crystallographic analyses.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Phytogenic / chemistry
-
Antineoplastic Agents, Phytogenic / isolation & purification*
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Crystallography, X-Ray
-
Drug Screening Assays, Antitumor
-
Humans
-
Korea
-
Molecular Conformation
-
Molecular Structure
-
Moraceae / chemistry*
-
Nuclear Magnetic Resonance, Biomolecular
-
Plant Bark / chemistry
-
Plants, Medicinal / chemistry*
-
Tumor Cells, Cultured
-
Xanthones / chemistry
-
Xanthones / isolation & purification*
-
Xanthones / pharmacology
Substances
-
2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9H-xanthen-9-one
-
Antineoplastic Agents, Phytogenic
-
Xanthones
-
cudraxanthone L
-
macluraxanthone B